Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

More On 009420.KS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


HanAll Biopharma Co., Ltd. (009420.KS)

-KSC
4,210.00 Up 150.00(3.69%) 11:47PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Net Income 528,000   (12,708,000) (5,196,000) (1,590,000)
Operating Activities, Cash Flows Provided By or Used In
Depreciation560,000  546,000  489,000  459,000  
Adjustments To Net Income -   -   -   -  
Changes In Accounts Receivables(1,754,000)2,970,000  663,000  (1,128,000)
Changes In Liabilities -   -   -   -  
Changes In Inventories2,328,000  (1,496,000)(1,404,000)(218,000)
Changes In Other Operating Activities(3,556,000)(417,000)1,019,000  (402,000)
Total Cash Flow From Operating Activities (1,450,000) (3,150,000) (570,000) (3,148,000)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(388,000)(1,995,000)(1,132,000)(748,000)
Investments -   -   -   -  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities (1,095,000) 6,046,000   (1,757,000) 7,007,000  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock -   -   -   -  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities(707,000)8,005,000  (631,000)7,749,000  
Total Cash Flows From Financing Activities (1,080,000) (717,000) (9,761,000) (1,892,000)
Effect Of Exchange Rate Changes24,000  (78,000)(50,000)32,000  
Change In Cash and Cash Equivalents (3,601,000) 2,101,000   (12,137,000) 1,999,000  

Currency in KRW.